E-LIB Suche - Ergebnisse für: Tsumura, Shinsuke

1

Safety and efficacy of osimertinib rechallenge or continuat..:

Imaji, Mihoko ; Fujimoto, Daichi ; Sato, Yuki...
European Journal of Cancer. 179 (2023) - p. 15-24 , 2023

Link: https://doi.org/10.1016/..

2

Corrigendum to "Osimertinib as first-line treatment for eld..:

Sakata, Yoshihiko ; Saito, Go ; Sakata, Shinya...
Lung Cancer. , 2023

Link: https://doi.org/10.1016/..

3

Osimertinib as first-line treatment for elderly patients wi..:

Sakata, Yoshihiko ; Saito, Go ; Sakata, Shinya...
Lung Cancer. 186 (2023) - p. 107426 , 2023

Link: https://doi.org/10.1016/..

4

Prognosis of stage I non-small cell lung cancer patients ag..:

Kashiwabara, Kosuke ; Fujii, Shinji ; Tsumura, Shinsuke.
Cancer Treatment and Research Communications. 33 (2022) - p. 100642 , 2022

Link: https://doi.org/10.1016/..

5

Efficacy and safety of transbronchial microwave ablation th..:

Kashiwabara, Kosuke ; Fujii, Shinji ; Tsumura, Shinsuke..
Journal of Cancer Research and Clinical Oncology. 147 (2021) 9 - p. 2751-2757 , 2021

Link: https://doi.org/10.1007/..

6

Osimertinib as first-line treatment for advanced epidermal ..:

Sakata, Yoshihiko ; Sakata, Shinya ; Oya, Yuko...
European Journal of Cancer. 159 (2021) - p. 144-153 , 2021

Link: https://doi.org/10.1016/..

7

Overall survival of super-elderly (85 years or older) advan..:

Kashiwabara, Kosuke ; Fujii, Shinji ; Tsumura, Shinsuke.
Journal of Cancer Research and Clinical Oncology. 147 (2020) 1 - p. 287-293 , 2020

Link: https://doi.org/10.1007/..

8

Additional bevacizumab in EGFR-mutant lung adenocarcinoma p..:

Kashiwabara, Kosuke ; Fujii, Shinji ; Tsumura, Shinsuke..
Cancer Treatment and Research Communications. 22 (2020) - p. 100163 , 2020

Link: https://doi.org/10.1016/..

9

Survival Analysis for Patients with ALK Rearrangement-Posit..:

Iwama, Eiji ; Goto, Yasushi ; Murakami, Haruyasu...
The Oncologist. 25 (2019) 4 - p. 306-e618 , 2019

Link: https://doi.org/10.1634/..

10

Outcome in advanced non-small cell lung cancer patients wit..:

Kashiwabara, Kosuke ; Semba, Hiroshi ; Fujii, Shinji.
Cancer Chemotherapy and Pharmacology. 79 (2017) 4 - p. 705-710 , 2017

Link: https://doi.org/10.1007/..

11

Tolerability and efficacy of afatinib at a low starting dos..:

Kashiwabara, Kosuke ; Semba, Hiroshi ; Fujii, Shinji.
Respiratory Investigation. 54 (2016) 6 - p. 468-472 , 2016

Link: https://doi.org/10.1016/..

12

Fibroproliferative changes on high-resolution CT in the acu..:

Ichikado, Kazuya ; Muranaka, Hiroyuki ; Gushima, Yasuhiro...
BMJ Open. 2 (2012) 2 - p. e000545 , 2012

Link: https://doi.org/10.1136/..

13

Survival Analysis for Patients with ALK Rearrangement‐Posit..:

Iwama, Eiji ; Goto, Yasushi ; Murakami, Haruyasu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160311/. , 2019

Link: http://www.ncbi.nlm.nih...

14

Fibroproliferative changes on high-resolution CT in the acu..:

Ichikado, Kazuya ; Muranaka, Hiroyuki ; Gushima, Yasuhiro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293132. , 2012

Link: http://www.ncbi.nlm.nih...

15

Prognosis of stage I non-small cell lung cancer patients ag..:

Kosuke Kashiwabara ; Shinji Fujii ; Shinsuke Tsumura.
http://www.sciencedirect.com/science/article/pii/S2468294222001332. , 2022

Link: https://doi.org/10.1016/..